UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.85 +0.83 (+1.06%) GOLD FUTURES
2,392.60 +32.70 (+1.39%) DOW
39,852.01 +293.90 (+0.74%) Bitcoin GBP
51,987.50 +3,520.91 (+7.26%)
Merit Medical Systems, Inc. (MMSI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:24PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 4.79B |
| Enterprise value | 5.08B |
| Trailing P/E | 47.36 |
| Forward P/E | 24.75 |
| PEG ratio (5-yr expected) | 2.15 |
| Price/sales (ttm) | 3.75 |
| Price/book (mrq) | 3.86 |
| Enterprise value/revenue | 3.96 |
| Enterprise value/EBITDA | 20.54 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.91 |
| 52-week change 3 | -1.83% |
| S&P500 52-week change 3 | 26.16% |
| 52-week high 3 | 85.62 |
| 52-week low 3 | 62.58 |
| 50-day moving average 3 | 74.55 |
| 200-day moving average 3 | 72.54 |
Share statistics
| Avg vol (3-month) 3 | 398.87k |
| Avg vol (10-day) 3 | 398.69k |
| Shares outstanding 5 | 58.11M |
| Implied shares outstanding 6 | 58.11M |
| Float 8 | 56.71M |
| % held by insiders 1 | 2.44% |
| % held by institutions 1 | 102.89% |
| Shares short (30 Apr 2024) 4 | 2.26M |
| Short ratio (30 Apr 2024) 4 | 6.74 |
| Short % of float (30 Apr 2024) 4 | 5.69% |
| Short % of shares outstanding (30 Apr 2024) 4 | 3.88% |
| Shares short (prior month 28 Mar 2024) 4 | 1.98M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 5:4 |
| Last split date 3 | 06 May 2011 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 7.94% |
| Operating margin (ttm) | 11.07% |
Management effectiveness
| Return on assets (ttm) | 4.25% |
| Return on equity (ttm) | 8.45% |
Income statement
| Revenue (ttm) | 1.28B |
| Revenue per share (ttm) | 22.22 |
| Quarterly revenue growth (yoy) | 8.70% |
| Gross profit (ttm) | N/A |
| EBITDA | 229.42M |
| Net income avi to common (ttm) | 101.95M |
| Diluted EPS (ttm) | 1.74 |
| Quarterly earnings growth (yoy) | 36.40% |
Balance sheet
| Total cash (mrq) | 583.07M |
| Total cash per share (mrq) | 10.03 |
| Total debt (mrq) | 872.75M |
| Total debt/equity (mrq) | 70.37% |
| Current ratio (mrq) | 6.03 |
| Book value per share (mrq) | 21.34 |
Cash flow statement
| Operating cash flow (ttm) | 166.82M |
| Levered free cash flow (ttm) | 120.17M |
© 2024 Yahoo. All rights reserved.